Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethinylestradiol and cyproterone acetate versus medroxyprogesterone acetate for dysfunctional uterine bleeding
ChiCTR-TRC-11002030Phase 4Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jan 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in dysfunctional uterine bleeding (DUB) comparing Ethinylestradiol and cyproterone acetate group with MPA group (2 arms). Primary endpoints: weight, height and 6 more. Started Jan 2012; status: completed.
02
Drugs
ethinyl estradiol + cyproteronemedroxyprogesterone acetate
03
Conditions
dysfunctional uterine bleeding (DUB)
Beyond the preview
Go deeper on ChiCTR-TRC-11002030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11002030.